Inactive Instrument

News ACLS THER Nasdaq

Stocks

Biotechnology & Medical Research

End-of-day quote Nasdaq
- ^USD	-

09-01	Canaccord Genuity Initiates Aclaris Therapeutics at Buy With $10 Price Target	MT
08-06	Aclaris Therapeutics Gets Fast-Track Designation for Inflammation Treatment Modzatinib	DJ

All News

Mentions Relevance

09-03	Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference	AQ
09-01	Canaccord Genuity Initiates Aclaris Therapeutics at Buy With $10 Price Target	MT
08-06	Aclaris Therapeutics Gets Fast-Track Designation for Inflammation Treatment Modzatinib	DJ
08-06	Aclaris Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-06	Aclaris Therapeutics Receives Fast Track Designation for Modzatinib (ATI-2138) for Moderate to Severe Lichen Planus (LP)	AQ
08-06	Aclaris Therapeutics, Inc. Receives Fast Track Designation For Modzatinib (ATI-2138) For Moderate To Severe Lichen Planus	CI
08-06	Earnings Flash (ACRS) Aclaris Therapeutics, Inc. Reports Q2 Revenue $1.6M, vs. FactSet Est of $1.4M	MT
08-06	Earnings Flash (ACRS) Aclaris Therapeutics Posts Q2 Net Loss $0.15 a Share, vs. FactSet Est of $0.16 Loss	MT
08-06	Aclaris: Q2 Earnings Snapshot	AQ
08-06	Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update	AQ
08-05	Aclaris Therapeutics Inc and U.S. Food and Drug Administration Grant Fast Track Designation for Modzatinib for Lichen Planus	CI
06-29	Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell Small Cap Comp Growth Benchmark	CI
06-29	Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell 2500 Growth Benchmark	CI
06-29	Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell 2000 Growth Benchmark	CI
06-29	Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell 3000E Growth Benchmark	CI
06-28	Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell Microcap Growth Benchmark Index	CI
06-28	Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell 3000 Growth Benchmark	CI
06-21	Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to S&P Pharmaceuticals Select Industry Index	CI
05-28	Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference	AQ
05-14	Aclaris Therapeutics, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-14-2026 09:35 AM
05-08	Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference	AQ
05-07	Aclaris Therapeutics : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q)	PU
05-07	Aclaris Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-07	Aclaris: Q1 Earnings Snapshot	AQ
05-07	Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update	AQ

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!